Sonn, Iki
Honda-Ozaki, Fumiko
Yoshimatsu, Sho
Morimoto, Satoru
Watanabe, Hirotaka
Okano, Hideyuki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15bk0104027h0003)
Japan Agency for Medical Research and Development (16bk0104016h0004)
Japan Agency for Medical Research and Development (17bk0104016h0005)
Japan Agency for Medical Research and Development (JP15bm0609003)
Japan Agency for Medical Research and Development (JP16bm0609003)
Japan Agency for Medical Research and Development (JP17bm0804003)
Japan Agency for Medical Research and Development (JP18bm0804003)
Japan Agency for Medical Research and Development (JP19bm0804003)
Japan Agency for Medical Research and Development (JP20bm0804003)
Japan Agency for Medical Research and Development (JP21bm0804003)
Japan Society for the Promotion of Science (JP21J12528)
Article History
Received: 31 December 2021
Accepted: 22 February 2022
First Online: 1 July 2022
Declarations
:
: No applicable.
: Human ethics approval was obtained from the Ethics Committee of Keio University School of Medicine (Approval Number: 20080016).
: The Program for Initiative Research Projects from Keio University to H.O. F.O. is employed by K Pharma, Inc., and H.O. received research funding from K Pharma, Inc. The other authors declare that they have no competing interests.